Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 8 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 9 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

Advertise on Science & Enterprise

 

Tablet, laptop

(Pixnio)

Science & Enterprise attracts a unique combination of business, academic, scientific, and technological readers looking for serious news on matters with direct consequences for their companies, organizations, or individual careers. To reach these readers, Science & Enterprise offers guest posts as native advertising opportunities.

Guest posts run about 500 words, and relate to the broad themes of science, technology, and business. You only need to provide text with links, subject to our review. We can provide a suitable image to go with the text, if you wish.

Please note that we label guest posts as sponsored content and do not accept any attributes on links, such as do-follow, that violate Google’s guidelines. And we do not accept any content related to gambling, gaming, fantasy sports, smoking, firearms, pornography, sexually-oriented businesses, or predatory loans.

The latest media kit for Science & Enterprise describing our editorial objectives and advertising opportunities is now available for download. For more information and current rates, please contact sciencebusiness [at] technewslit [dot] com.

*     *     *